S&P 500 7,798.99 +0.65%Nasdaq 26,803.03 +0.81%Dow 53,839.99 +0.13%Russell 2000 3,052.85 +0.24%as of 2026-08-13 close
The SmallCap Signal
Small & mid-cap intelligence for the next market cycle
Small Caps

Blaize cuts its 2026 revenue outlook by two-thirds while CPI Aerostructures posts a profit: Thursday night's small-cap earnings

Three small companies reported after Thursday's close and told three different stories. Blaize took its full-year revenue guidance from $130 million to $40-$43 million, CPI Aerostructures turned a 4.4% gross margin into 22%, and CapsoVision grew revenue 10% while its operating loss widened by more than half.
Blaize cuts its 2026 revenue outlook by two-thirds while CPI Aerostructures posts a profit: Thursday night's small-cap earnings

Thursday's after-close window produced an unusually clean contrast in small-cap earnings: one company that lost control of its forecast, one that finally converted a turnaround into reported profit, and one growing steadily but burning cash faster than it sells product. None of the three is large enough that a headline index will notice. All three are large enough to matter to the people holding them.

The most consequential release came from Blaize Holdings (Nasdaq: BZAI), an edge artificial-intelligence chip and platform company, which put out its second-quarter results after Thursday's close. Revenue for the quarter was $12.0 million, against $2.7 million in the first quarter and $2.0 million in the same quarter of 2025, per the company's release. First-half revenue was $14.7 million versus $3.0 million a year earlier. On the top line alone, that reads as a breakout.

The rest of the release did not. Gross margin fell to 8% in the second quarter from 58% in the first, which the company attributed to a product mix weighted toward lower-margin third-party servers. Net loss widened to $28.8 million from $22.7 million in the first quarter. Adjusted EBITDA loss was $20.9 million, against $13.9 million in the prior quarter. Cash and equivalents stood at $36.8 million as of June 30.

Then came the guidance. Blaize now expects full-year 2026 revenue of $40.0 million to $43.0 million and an adjusted EBITDA loss of $62.0 million to $65.0 million. That revenue range is roughly a third of the $130 million figure the company had reaffirmed earlier in the year, as reported by Seeking Alpha at the time and confirmed in MarketBeat's account of Thursday's earnings call. MarketBeat also reported that Blaize recorded a $7.1 million provision against its remaining receivable from a customer identified as Starshine, with chief financial officer Harminder Sehmi saying of that account that "there is meaningful uncertainty as to whether it will progress further."

Chief executive Dinakar Munagala addressed the reduction directly in the release. "While we delivered solid sequential revenue growth in the second quarter, we have reduced our full-year revenue outlook. What changed is the pace at which opportunity converts into orders, alongside materially higher memory pricing," he said. On the earnings call he was more specific about the mechanism, telling analysts, per MarketBeat's account: "Several engagements have not converted into orders, including some where pilots were completed successfully." Sehmi described the basis for the new number: "Our revised full-year revenue outlook is weighted toward revenue from our largest customer and is based on binding, non-cancellable purchase orders that we believe we can fulfill with inventory commitments already made or planned." MarketBeat reported that the delayed opportunities remain in the company's pipeline and have not been lost.

The conservatism is defensible; the arithmetic is the problem. A guided adjusted EBITDA loss of $62 million to $65 million for the year against $36.8 million of cash at the halfway mark leaves Blaize dependent on further financing, and the company already took in $32.8 million of net proceeds from an equity offering during the second quarter, per MarketBeat's summary of the call. Existing shareholders should assume dilution is on the table. Blaize also flagged roughly $34.7 million of stock-based compensation and about 141 million weighted average shares in its 2026 outlook. Separately, the company said it holds a binding agreement for 2,000 servers worth about $70.0 million at current memory pricing, of which roughly $20.0 million is expected to be recognised in the second half of 2026 and about $50.0 million carried into 2027 as contracted backlog. That backlog is real, but it is concentrated, and its value is explicitly tied to a memory market that just moved against the company. Because the release landed after the close, the market's verdict will come at Friday's open.

CPI Aerostructures (NYSE American: CVU) reported the opposite kind of quarter. The aerostructures supplier posted second-quarter revenue of $17.6 million, up from $15.2 million a year earlier, with gross profit of $3.9 million against $0.7 million. Gross margin went from 4.4% to 22.0%. The company swung to net income of $0.7 million, or $0.05 per share, from a loss of $1.3 million, or $0.10 per share. Adjusted EBITDA was $1.4 million against a $1.7 million loss a year earlier.

The six-month figures show the same shape: revenue of $34.9 million versus $30.6 million, gross profit of $8.4 million versus $2.3 million, and net income of $1.9 million against a $2.6 million loss. "Our six months performance showcases the results of a focused growth strategy and disciplined execution, delivering year-over-year gains across every major metric," chief executive Dorith Hakim said in the release. She described the period's $3.5 million of adjusted EBITDA — a non-GAAP measure — as "a clear inflection point for the business, even when normalizing for the A-10 program impact." CPI reported total backlog of $533 million with more than $100 million funded, and $62 million of contract awards this year for new generation products.

The balance sheet is where readers should slow down. CPI Aerostructures held $835,875 in cash as of June 30 against total assets of $78.7 million, with $9.6 million of long-term debt excluding the current portion and $9.2 million drawn on its line of credit. This is a company with roughly 13.2 million shares outstanding and a market capitalisation near $74.8 million, based on WallStreetZen's data, which closed Thursday at $5.66, up 3.28%. A micro-cap running under a million dollars of cash has essentially no buffer against a working-capital shock, a customer payment delay or a credit-facility renegotiation, regardless of how good the margin trend looks. The backlog number and the cash number should be read together, not separately.

CapsoVision (Nasdaq: CV), which makes the CapsoCam Plus capsule endoscopy system, reported second-quarter revenue of $3.6 million, up 10% from $3.3 million a year earlier, with first-half revenue of $6.435 million against $6.098 million. The company said capsule unit sales rose 13%, partly offset by an average selling price decline of roughly 3%. Gross profit was $1.9 million, up 3%, and gross margin narrowed to 51% from 55%.

Costs moved faster than sales. CapsoVision's operating loss widened to $7.6 million from $4.7 million a year earlier, and the first-half operating loss reached $14.7 million against $10.0 million. Cash and equivalents were $9.1 million at June 30. Against that, the company disclosed it has entered an at-the-market equity offering agreement with Cantor for up to $100 million — a facility that size relative to a roughly $343 million market capitalisation, per StockTitan's data, represents a substantial potential source of dilution if drawn. Management said it launched its AI Highlights feature commercially in the European Union and other international markets and anticipates FDA clearance by the third quarter of 2026, and that a 510(k) submission for CapsoCam Colon is planned for the fourth quarter. Both are company expectations, not regulatory commitments.

What links the three is a question about the distance between a contract and a dollar. Blaize has $70 million of signed server business and had to cut its revenue forecast by two-thirds anyway. CPI Aerostructures has $533 million of backlog and $835,875 of cash. CapsoVision has a growing installed base — the company said CapsoCam Plus has been used by more than 176,000 patients as of June 30 — and an operating loss running at roughly twice quarterly revenue. In small caps, backlog, pipeline and installed base are leading indicators of nothing in particular until they convert, and the conversion schedule is where the risk actually sits.

All three companies report on a schedule that puts their next update in the autumn. All three carry the standard small-cap financing risk in a visible form: Blaize's guided full-year adjusted EBITDA loss is larger than the cash it held at June 30; CapsoVision's at-the-market facility is roughly eleven times its June 30 cash balance; CPI Aerostructures is operating on under a million dollars of cash with a credit line already drawn. Readers should treat all three as speculative and size any exposure with that in mind. Nothing here is a recommendation to buy or sell.

This article is for general information only and is not investment advice. Figures are as reported by the cited sources at time of writing.

Related coverage